TARDBP and dermatopathia pigmentosa reticularis: Neuropathological and biomarker studies suggest that targeting early prodromal DPR pathology may prevent the later onset of symptoms and the appearance of TDP-43 pathology and resultant neurodegeneration [5, 23, 50, 93].